Literature DB >> 11821846

Antibodies for defense against biological attack.

Arturo Casadevall1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11821846     DOI： 10.1038/nbt0202-114

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.

Authors:  Avanish K Varshney; Xiaobo Wang; Emily Cook; Kaushik Dutta; Matthew D Scharff; Michael J Goger; Bettina C Fries
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

2.  mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.

Authors:  Thomas R Kozel; William J Murphy; Suzanne Brandt; Bruce R Blazar; Julie A Lovchik; Peter Thorkildson; Ann Percival; C Rick Lyons
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

3.  Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.

Authors:  Zhaochun Chen; Patricia Earl; Jeffrey Americo; Inger Damon; Scott K Smith; Fujuan Yu; Andrew Sebrell; Suzanne Emerson; Gary Cohen; Roselyn J Eisenberg; Inna Gorshkova; Peter Schuck; William Satterfield; Bernard Moss; Robert Purcell
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

Review 4.  Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.

Authors:  Laura M Zarebski; Kerrie Vaughan; John Sidney; Bjoern Peters; Howard Grey; Kim D Janda; Arturo Casadevall; Alessandro Sette
Journal:  Expert Rev Vaccines       Date:  2008-02       Impact factor: 5.217

5.  Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.

Authors:  Jianhua Sui; Wenhui Li; Akikazu Murakami; Azaibi Tamin; Leslie J Matthews; Swee Kee Wong; Michael J Moore; Aimee St Clair Tallarico; Mobolaji Olurinde; Hyeryun Choe; Larry J Anderson; William J Bellini; Michael Farzan; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

6.  DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).

Authors:  Rebecca Brocato; Matthew Josleyn; John Ballantyne; Pablo Vial; Jay W Hooper
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 7.  Antibody manufacture in transgenic animals and comparisons with other systems.

Authors:  Louis Marie Houdebine
Journal:  Curr Opin Biotechnol       Date:  2002-12       Impact factor: 9.740

Review 8.  Immunomodulators as an antimicrobial tool.

Authors:  Liise-anne Pirofski; Arturo Casadevall
Journal:  Curr Opin Microbiol       Date:  2006-08-22       Impact factor: 7.934

9.  Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases.

Authors:  J Rogers; R J Schoepp; O Schröder; T L Clements; T F Holland; J Q Li; J Li; L M Lewis; R P Dirmeier; G J Frey; X Tan; K Wong; G Woodnutt; M Keller; D S Reed; B E Kimmel; E C Tozer
Journal:  Protein Eng Des Sel       Date:  2008-05-13       Impact factor: 1.650
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.